RNA Binding Proteins are Pivotal Regulators of Cancer Radioresistance and Potential Targets for Preventing Tumor Recurrence

Thasma Loganathbabu, V.K.T. and Satishkartik, S. and Karthikeyan, V. and Chattopadhyay, S. and Shriya, P. and Ganesh, H.N. and Rangasamy, K. and Ramalingam, S. and Aruljothi, A.K. (2025) RNA Binding Proteins are Pivotal Regulators of Cancer Radioresistance and Potential Targets for Preventing Tumor Recurrence. Current Pediatric Reviews. ISSN 15733963; 18756336

Full text not available from this repository.

Abstract

RNA-binding proteins (RBPs) regulate gene expression at the post-transcriptional level and are important factors in cancer progression and response to various therapeutic strategies. Radioresistance, an obstacle caused due to various intrinsic and extrinsic factors, remains a major hindrance in the treatment of cancer and could lead to tumor recurrence. Though research is being conducted on the cause and association of radioresistance with various cellular and environmental factors, there remains much to be explored and discovered. The roles of several RNA-binding proteins in tumor progression and metastasis are well documented. In addition, recent studies suggest the connection between Cancer Stem Cells (CSCs) and chemoresistance. We and others have extensively studied the regulatory role of RBPs in regulating CSCs. Resistance to radiation therapy and the involvement of RBPs in this process is under-studied. In this review, we have provided an updated compilation of the significant role played by RBPs in radioresistance. © 2025 Elsevier B.V., All rights reserved.

Item Type: Article
Subjects: Medicine > Oncology
Divisions: Engineering and Technology > Vinayaka Mission's Kirupananda Variyar Engineering College, Salem > Pharmaceutical Engineering
Depositing User: Unnamed user with email techsupport@mosys.org
Date Deposited: 11 Dec 2025 17:02
Last Modified: 11 Dec 2025 17:05
URI: https://vmuir.mosys.org/id/eprint/5392

Actions (login required)

View Item
View Item